Cargando…

The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study

BACKGROUND: Multimorbidity and polypharmacy are common problems among the older population globally. They not only reduce the quality of life of older adults but also increase the prevalence of potentially inappropriate medication (PIM) use. This study aimed to examine the prevalence and the predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Fangyuan, Liao, Shili, Chen, Zhaoyan, Xu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506761/
https://www.ncbi.nlm.nih.gov/pubmed/34734035
http://dx.doi.org/10.21037/atm-21-4238
_version_ 1784581754631225344
author Tian, Fangyuan
Liao, Shili
Chen, Zhaoyan
Xu, Ting
author_facet Tian, Fangyuan
Liao, Shili
Chen, Zhaoyan
Xu, Ting
author_sort Tian, Fangyuan
collection PubMed
description BACKGROUND: Multimorbidity and polypharmacy are common problems among the older population globally. They not only reduce the quality of life of older adults but also increase the prevalence of potentially inappropriate medication (PIM) use. This study aimed to examine the prevalence and the predictors of PIMs in hospitalized geriatric patients with multimorbidity and polypharmacy in Chengdu based on the 2015 American Geriatric Society Beers Criteria (2015 AGS Beers Criteria) and 2019 American Geriatric Society Beers Criteria (2019 AGS Beers Criteria). METHODS: From 2016 to 2018, a cross-sectional study was conducted using electronic medical data from nine tertiary hospitals in Chengdu. The 2019 and 2015 AGS Beers Criteria were used to evaluate the PIM status of older inpatients (age ≥65 years), and logistic regression was used to identify the risk factors for PIM use. RESULTS: A total of 17,352 inpatients were included in the study between 2016 and 2018. The prevalence of PIM use based on the 2019 AGS Beers Criteria (72.54%) was slightly higher than that based on the 2015 AGS Beers Criteria (70.10%). Further, the prevalence of PIM use based on the 2019 AGS Beers Criteria showed an increasing trend, from 71.17% in 2016 to 73.39% in 2018. Logistic regression demonstrated that female, advanced age, and polypharmacy were positively associated with PIM use in older adults. The most frequently used PIMs in the inpatients were diuretics, benzodiazepines, non-steroidal anti-inflammatory drugs, antipsychotics, and selective serotonin reuptake inhibitors. CONCLUSIONS: There is a high prevalence of PIM use in older inpatients with multimorbidity and polypharmacy in Chengdu. The 2019 AGS Beers Criteria is more sensitive for evaluating older adults in Chengdu than the 2015 AGS Beers Criteria. Further, based on the 2019 AGS Beers Criteria, the prevalence of PIM use is increasing year by year. Research on interventions rationing PIM use in the geriatric population in Chengdu are necessary in the future.
format Online
Article
Text
id pubmed-8506761
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-85067612021-11-02 The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study Tian, Fangyuan Liao, Shili Chen, Zhaoyan Xu, Ting Ann Transl Med Original Article BACKGROUND: Multimorbidity and polypharmacy are common problems among the older population globally. They not only reduce the quality of life of older adults but also increase the prevalence of potentially inappropriate medication (PIM) use. This study aimed to examine the prevalence and the predictors of PIMs in hospitalized geriatric patients with multimorbidity and polypharmacy in Chengdu based on the 2015 American Geriatric Society Beers Criteria (2015 AGS Beers Criteria) and 2019 American Geriatric Society Beers Criteria (2019 AGS Beers Criteria). METHODS: From 2016 to 2018, a cross-sectional study was conducted using electronic medical data from nine tertiary hospitals in Chengdu. The 2019 and 2015 AGS Beers Criteria were used to evaluate the PIM status of older inpatients (age ≥65 years), and logistic regression was used to identify the risk factors for PIM use. RESULTS: A total of 17,352 inpatients were included in the study between 2016 and 2018. The prevalence of PIM use based on the 2019 AGS Beers Criteria (72.54%) was slightly higher than that based on the 2015 AGS Beers Criteria (70.10%). Further, the prevalence of PIM use based on the 2019 AGS Beers Criteria showed an increasing trend, from 71.17% in 2016 to 73.39% in 2018. Logistic regression demonstrated that female, advanced age, and polypharmacy were positively associated with PIM use in older adults. The most frequently used PIMs in the inpatients were diuretics, benzodiazepines, non-steroidal anti-inflammatory drugs, antipsychotics, and selective serotonin reuptake inhibitors. CONCLUSIONS: There is a high prevalence of PIM use in older inpatients with multimorbidity and polypharmacy in Chengdu. The 2019 AGS Beers Criteria is more sensitive for evaluating older adults in Chengdu than the 2015 AGS Beers Criteria. Further, based on the 2019 AGS Beers Criteria, the prevalence of PIM use is increasing year by year. Research on interventions rationing PIM use in the geriatric population in Chengdu are necessary in the future. AME Publishing Company 2021-09 /pmc/articles/PMC8506761/ /pubmed/34734035 http://dx.doi.org/10.21037/atm-21-4238 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Tian, Fangyuan
Liao, Shili
Chen, Zhaoyan
Xu, Ting
The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
title The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
title_full The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
title_fullStr The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
title_full_unstemmed The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
title_short The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
title_sort prevalence and risk factors of potentially inappropriate medication use in older chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506761/
https://www.ncbi.nlm.nih.gov/pubmed/34734035
http://dx.doi.org/10.21037/atm-21-4238
work_keys_str_mv AT tianfangyuan theprevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy
AT liaoshili theprevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy
AT chenzhaoyan theprevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy
AT xuting theprevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy
AT tianfangyuan prevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy
AT liaoshili prevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy
AT chenzhaoyan prevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy
AT xuting prevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy